---
title: Leveraging Real-World Evidence for Pharma companies - Best practices
description: Real-world evidence generation guidance for the pharma industry, particularly medical affairs and market access departments.
---

[![Logo Observia](https://hub.observia-group.com/hs-fs/hubfs/LOGO-observia-2021-RVB_petit.png?width=222&height=50&name=LOGO-observia-2021-RVB_petit.png "Logo Observia")](https://hub.observia-group.com/?hsLang=en)

# **Unlocking real-world evidence for pharma  success** Best practices for medical affairs, data-generation and market access departments

The pharmaceutical industry must demonstrate the real-world effectiveness of its therapies beyond clinical trials. As payers' demand for value-based care rises, using RWE is vital to prove the true impact of treatments across healthcare systems.

How can you adjust your strategies to this changing landscape? Let's deep dive! 

Copyright © 2026,